Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PARNAX LAB Gains 7%; BSE HEALTHCARE Index Down 0.9%
Mon, 21 Oct 16:8

PARNAX LAB Gains 7%; BSE HEALTHCARE Index Down 0.9%Image source: peterschreiber.media/www.istockphoto.com

PARNAX LAB share price has zoomed 7% and is presently trading at Rs 159.0.

Meanwhile, the BSE HEALTHCARE index is at 43,859.9 (down 0.9%).

Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 2.5%) and GLAND PHARMA (up 1.7%).

SUN PHARMA ADV. RES. (down 3.0%) and LAURUS LABS (down 2.8%) are among the top losers today.

Over the last one year, PARNAX LAB has moved up from Rs 96.0 to Rs 159.0, registering a gain of Rs 63.0 (up 65.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,236.4 to 43,859.9, registering a gain of 55.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 178.3%), SUVEN PHARMACEUTICALS (up 118.4%) and Glenmark Pharma (up 114.0%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,151.3 (down 0.1%).

The top losers among the BSE Sensex today are Kotak Bank (down 4.7%) and Bajaj Finserv (down 3.0%). The most traded stocks in the BSE Sensex are HDFC Bank and Tata Steel.

In the meantime, NSE Nifty is at 24,739.5 (down 0.5%). Tata Consumer Products and Kotak Bank are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,428.1 to 81,151.3, registering a gain of 14,723.2 points (up 22.2%).

PARNAX LAB Financial Update...

PARNAX LAB net profit grew 19.8% YoY to Rs 40 million for the quarter ended June 2024, compared to a profit of Rs 33 million a year ago. Net sales rose 2.8% to Rs 501 million during the period as against Rs 487 million in April-June 2023.

For the year ended March 2023, PARNAX LAB reported 4.5% increase in net profit to Rs 86 million compared to net profit of Rs 83 million during FY22. Revenue of the company grew 2.8% to Rs 1,676 million during FY23.

The current Price to earnings ratio of PARNAX LAB, based on rolling 12 month earnings, stands at 17.8.


Equitymaster requests your view! Post a comment on "PARNAX LAB Gains 7%; BSE HEALTHCARE Index Down 0.9%". Click here!